Literature DB >> 21294398

Toxicity evaluation of sappan wood extract in rats.

Seeewaboon Sireeratawong1, Pritsana Piyabhan, Tippaya Singhalak, Yuvadee Wongkrajang, Rungravi Temsiririrkkul, Jakkapun Punsrirat, Nongluck Ruangwises, Sumarn Saraya, Nusiri Lerdvuthisopon, Kanjana Jaijoy.   

Abstract

BACKGROUND: The heartwood of Caesalpinia sappan L. or sappan wood has long been used in folk medicines to treat tuberculosis, diarrhea, dysentery, skin infections and anemia.
OBJECTIVE: To study the acute and subacute toxicities of sappan wood extract in rats. MATERIAL AND
METHOD: For studying acute toxicity, a single oral dose of 5000 mg/kg of sappan wood was administered to rats. Subacute toxicity was studied by the daily oral administration of the extract at the doses of 250, 500 and 1000 mg/kg body weight for consecutive 30 days.
RESULTS: The extract of sappan wood (5000 mg/kg) showed no toxicity in terms of general behavior change, mortality, or change in gross appearance of internal organs. Subacute toxicity study showed no abnormalities in treatment groups as compared to the controls. Body and organ weights, hematological, blood chemical, necropsy, and histopathological parameter of all groups were similar.
CONCLUSION: Sappan wood extract did not produce any acute or subacute toxicity in both female and male rats.

Entities:  

Mesh:

Year:  2010        PMID: 21294398

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  8 in total

1.  Anti-inflammatory activity of an ethanolic Caesalpinia sappan extract in human chondrocytes and macrophages.

Authors:  Shengqian Q Wu; Miguel Otero; Frank M Unger; Mary B Goldring; Ampai Phrutivorapongkul; Catharina Chiari; Alexander Kolb; Helmut Viernstein; Stefan Toegel
Journal:  J Ethnopharmacol       Date:  2011-09-21       Impact factor: 4.360

2.  Caesalpinia sappan extract inhibits IL1β-mediated overexpression of matrix metalloproteinases in human chondrocytes.

Authors:  Stefan Toegel; Shengqian Q Wu; Miguel Otero; Mary B Goldring; Pimporn Leelapornpisid; Catharina Chiari; Alexander Kolb; Frank M Unger; Reinhard Windhager; Helmut Viernstein
Journal:  Genes Nutr       Date:  2011-08-18       Impact factor: 5.523

3.  Antibacterial Activity against Foodborne Pathogens and Inhibitory Effect on Anti-Inflammatory Mediators' Production of Brazilin-Enriched Extract from Caesalpinia sappan Linn.

Authors:  Thanawat Pattananandecha; Sutasinee Apichai; Jakaphun Julsrigival; Fumihiko Ogata; Naohito Kawasaki; Chalermpong Saenjum
Journal:  Plants (Basel)       Date:  2022-06-27

4.  Ethyl acetate extract of sappanwood alleviates experimental atherosclerosis in rats through changes in FGF21 and SREBP-2 expression.

Authors:  Quan Li; He Wang; Chunfang Zhang; Rui Tong; Huijun Chen; Rui Qie
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

5.  Medicinal plants with potential anti-arthritic activity.

Authors:  Manjusha Choudhary; Vipin Kumar; Hitesh Malhotra; Surender Singh
Journal:  J Intercult Ethnopharmacol       Date:  2015-03-14

6.  Caesalpinia sappan induces apoptotic cell death in ectopic endometrial 12Z cells through suppressing pyruvate dehydrogenase kinase 1 expression.

Authors:  Bo-Sung Kim; Tae-Wook Chung; Hee-Jung Choi; Sung-Jin Bae; Hye-Rin Cho; Syng-Ook Lee; Jung-Hye Choi; Jong Kil Joo; Ki-Tae Ha
Journal:  Exp Ther Med       Date:  2021-02-11       Impact factor: 2.447

7.  Brazilein from Caesalpinia sappan L. Antioxidant Inhibits Adipocyte Differentiation and Induces Apoptosis through Caspase-3 Activity and Anthelmintic Activities against Hymenolepis nana and Anisakis simplex.

Authors:  Chia-Hua Liang; Leong-Perng Chan; Tzung-Han Chou; Feng-Yu Chiang; Chuan-Min Yen; Pin-Ju Chen; Hsiou-Yu Ding; Rong-Jyh Lin
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-11       Impact factor: 2.629

8.  Protosappanin A protects against atherosclerosis via anti- hyperlipidemia, anti-inflammation and NF-κB signaling pathway in hyperlipidemic rabbits.

Authors:  Ying Huang; Yuan Qi; JianQing Du; DaiFu Zhang
Journal:  Iran J Basic Med Sci       Date:  2018-01       Impact factor: 2.699

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.